Skip to main content

Table 2 Baseline characteristics of participants in the original trial and analytic sample in the OmniHeart trial and the Atherosclerosis Risk in Communities (ARIC) Studya

From: Associations of circulating proteins with lipoprotein profiles: proteomic analyses from the OmniHeart randomized trial and the Atherosclerosis Risk in Communities (ARIC) Study

 

OmniHeart trial participants

(N = 164)

OmniHeart analytic sample

(N = 140)

ARIC Study analytic sample

(N = 11,201)

Age, y

53.1 (10.8)

53.7 (10.3)

57.1 (5.7)

Women, n (%)

73 (44.5)

67 (47.9)

6223 (55.5)

African American, n (%)

90 (54.9)

83 (59.3)

2612 (23.3)

Education, n (%)

   

 High school graduate or less

33 (20.1)

29 (20.7)

2428 (21.7)

 Some college

56 (34.1)

49 (35.0)

4709 (42.0)

 College graduate

75 (45.7)

62 (44.3)

4049 (36.1)

Smoking, n (%)

   

 Current smoker

18 (11.0)

17 (12.1)

2492 (22.2)

 Former smoker

46 (28.0)

39 (27.9)

4241 (37.9)

 Never smoker

100 (61.0)

84 (60.0)

4468 (39.8)

Current alcohol consumer, n (%)

73 (44.5)

59 (42.1)

6361 (56.7)

Total energy intake, kcal

2315 (1174)

2256 (1153)

—

BMI, kg/m2

30.3 (6.1)

30.5 (5.8)

27.9 (5.3)

BMI category, n (%)

   

 Not overweight or obese

34 (20.7)

25 (17.9)

3490 (31.2)

 Overweight

55 (33.5)

48 (34.3)

4479 (39.9)

 Obese

75 (45.7)

67 (47.9)

3232 (28.9)

SBP, mm Hg

131.2 (9.4)

131.2 (9.6)

121.5 (18.8)

DBP, mm Hg

77.0 (8.2)

77.2 (8.4)

71.9 (10.3)

Hypertensive status, n (%)b

32 (20.0)

28 (20.0)

4026 (35.9)

  1. a Values are n (%) for categorical variables and mean (standard deviation) for continuous variables
  2. b Hypertensive status was defined as SBP ≥ 140 mm Hg or DBP ≥ 90 mmHg in the OmniHeart trial. In the ARIC Study, hypertensive status was defined as SBP ≥ 140 mm Hg, DBP ≥ 90 mmHg, or use of antihypertensive medication use in the past 2 weeks
  3. — indicates that total energy intake was not assessed at ARIC visit 2
  4. DBP, diastolic blood pressure; SBP, systolic blood pressure